Join Dr. Michael Abramoff, MD, PhD, Founder and Executive Chairman of Digital Diagnostics as he takes part of the NIH Bridge 2 AI where he will talk about FDA regulatory pathways for AI clinical tools, with a particular focus on the equity/data drift/bias issues.
June 18, 2024 | 3:00 PM - 5:00 PM EST
Dr. Michael Abramoff, MD, PhD, Founder and Executive Chairman
Ethical, Legal, and Social Implications (ELSI) of Artificial Intelligence
Speaking Engagements